- Latest available (Revised)
- Original (As made)
There are currently no known outstanding effects for the The Market Surveillance (Northern Ireland) Regulations 2021, Paragraph 16.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
16.—(1) The power in sub-paragraph (2) is available to an officer of an enforcer acting [F1pursuant to—
(a)the duty in regulation 61(1A) or (1B) of the Medical Devices Regulations 2002,
(b)a duty in regulations made under section 15(1) of the Medicines and Medical Devices Act 2021, or
(c)the duty in regulation 26(1) or (2) of the Medical Devices (Northern Ireland Protocol) Regulations 2021.]
[F2(2) The officer may decommission or switch off any medical device to which the Medical Devices Regulations 2002, Regulation (EU) 2017/745 on medical devices or Regulation (EU) 2017/746 on in vitro diagnostic medical devices apply which is installed at a given location.]
(3) An enforcer may exercise the power in this paragraph—
(a)if an officer of the enforcer reasonably suspects a contravention of an obligation on an economic operator under any of—
(i)the Medical Devices Regulations 2002;
(ii)regulations made under section 15(1) of the Medicines and Medical Devices Act 2021; F3...
[F4(iii)the Medical Devices (Northern Ireland Protocol) Regulations 2021;
(iv)Regulation (EU) 2017/745 on medical devices; F5...]
[F6(v)Regulation (EU) 2017/746 on in vitro diagnostic medical devices; and]
(b)for the purpose of ascertaining (by means of testing or otherwise) whether there has been such non-compliance.
Textual Amendments
F1Words in Sch. 1 para. 16(1) substituted (27.7.2021) by The Medical Devices (Northern Ireland Protocol) Regulations 2021 (S.I. 2021/905), regs. 1(2), 43(3)(b)(i)
F2Sch. 1 para. 16(2) substituted (21.3.2024) by The Medical Devices (In Vitro Diagnostic Devices etc.) (Amendment) Regulations 2024 (S.I. 2024/221), regs. 1(2), 26(b)(i)
F3Word in Sch. 1 para. 16(3)(a)(ii) omitted (27.7.2021) by virtue of The Medical Devices (Northern Ireland Protocol) Regulations 2021 (S.I. 2021/905), regs. 1(2), 43(3)(b)(iii)
F4Sch. 1 para. 16(3)(a)(iii)(iv) inserted (27.7.2021) by The Medical Devices (Northern Ireland Protocol) Regulations 2021 (S.I. 2021/905), regs. 1(2), 43(3)(b)(iv)
F5Word in Sch. 1 para. 16(3)(a)(iv) omitted (21.3.2024) by virtue of The Medical Devices (In Vitro Diagnostic Devices etc.) (Amendment) Regulations 2024 (S.I. 2024/221), regs. 1(2), 26(b)(ii)
F6Sch. 1 para. 16(3)(a)(v) inserted (21.3.2024) by The Medical Devices (In Vitro Diagnostic Devices etc.) (Amendment) Regulations 2024 (S.I. 2024/221), regs. 1(2), 26(b)(ii)
Commencement Information
I1Sch. 1 para. 16 in force at 16.7.2021, see reg. 1(1)
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: